Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A9 | P48067 | 4/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | DRD2 | P14416 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | ITGA4 | P13612 | 2/20 | 0.36 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.36 |
| ▸ | ITGB7 | P26010 | 1/20 | 0.36 |
| ▸ | BRD4 | O60885 | 2/20 | 0.36 |
| ▸ | BRPF1 | P55201 | 2/20 | 0.36 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.36 |
| ▸ | TACR1 | P25103 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3240092 | 0.93 | SLC6A9 (0.47) | SLC6A9ALDH1A1DRD2POLBTACR1 | |
| SCHEMBL3241436 | 0.84 | SLC6A9 (0.41) | SLC6A9ALDH1A1ITGA4ITGB1ITGB7 | |
| SCHEMBL3244920 | 0.84 | ALDH1A1 (0.39) | SLC6A9ALDH1A1KCNK3KMT2A | |
| SCHEMBL3240097 | 0.82 | SLC6A9 (0.46) | SLC6A9ALDH1A1 | |
| SCHEMBL8265699 | 0.82 | KMT2A (0.35) | SLC6A9ALDH1A1BRD4BRPF1KCNK3 | |
| SCHEMBL3239965 | 0.82 | ROCK2 (0.40) | SLC6A9ALDH1A1POLBBRD4BRPF1 | |
| SCHEMBL3241381 | 0.81 | HCRTR1 (0.36) | SLC6A9ALDH1A1DRD2GAAKMT2A | |
| SCHEMBL3243834 | 0.81 | P2RX7 (0.39) | ALDH1A1KCNK3KMT2A | |
| SCHEMBL3238566 | 0.79 | SLC6A9 (0.40) | SLC6A9ALDH1A1KCNK3GAA | |
| SCHEMBL3232907 | 0.79 | ALDH1A1 (0.39) | SLC6A9ALDH1A1ITGB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7745533-B2 | Manufacture of stable low particle size organopolysiloxane emulsion | WACKER CHEMIE AG (DE) | 2010-06-29 | — | — | US | claimed |
| US-20070276087-A1 | MANUFACTURE OF STABLE LOW PARTICLE SIZE ORGANOPOLYSILOXANE EMUSLION | WACKER CHEMIE AG (DE) | 2007-11-29 | — | — | US | claimed |
| EP-4149415-B1 | SHAMPOO COMPOSITION COMPRISING ALKYL GLUCOSIDE | PROCTER & GAMBLE (US) | 2026-05-20 | — | — | EP | disclosed |
| EP-4337333-B1 | SHAMPOO COMPOSITION | PROCTER & GAMBLE (US) | 2026-04-15 | — | — | EP | disclosed |
| EP-4149416-B1 | SHAMPOO COMPOSITION COMPRISING DECYL GLUCOSIDE AND A CATIONIC GUAR | PROCTER & GAMBLE (US) | 2026-01-21 | — | — | EP | disclosed |
| EP-4352135-A1 | EMULSION POLYMERIZED EMULSIONS FROM POLYDIMETHYL SILOXANE MIXTURE AND CONSEQUENCE OF CYCLIC GENERATION IN FINAL EMULSION | Wacker Metroark Chemicals Pvt. Ltd. (IN) | 2024-04-17 | — | — | EP | disclosed |
| CN-117794508-A | Shampoo compositions | 宝洁公司 | 2024-03-29 | — | — | CN | disclosed |
| EP-4337333-A1 | SHAMPOO COMPOSITION | The Procter & Gamble Company (US) | 2024-03-20 | — | — | EP | disclosed |
| CN-117616070-A | Emulsion preparation from polydimethylsiloxane mixtures by emulsion polymerization and influence on the formation of cyclics in the emulsion product | 瓦克麦特罗克化学私营有限责任公司 | 2024-02-27 | — | — | CN | disclosed |
| US-11771635-B2 | Shampoo composition | THE PROCTER & GAMBLE COMPANY (US) | 2023-10-03 | — | — | US | disclosed |
| US-11679073-B2 | Hair compositions providing improved in-use wet feel | THE PROCTER & GAMBLE COMPANY (US) | 2023-06-20 | — | — | US | disclosed |
| WO-2013052771-A2 | PERSONAL CARE COMPOSITIONS AND METHODS OF MAKING SAME | THE PROCTER & GAMBLE COMPANY (US) | 2013-04-11 | — | — | WO | disclosed |
| US-7745642-B2 | Glycine transport inhibitors | GLAXO GROUP LIMITED (GB) | 2010-06-29 | — | — | US | disclosed |
| US-7745642-B2 | Glycine transport inhibitors | GLAXO GROUP LIMITED (GB) | 2010-06-29 | — | — | US | disclosed |
| US-7745533-B2 | Manufacture of stable low particle size organopolysiloxane emulsion | WACKER CHEMIE AG (DE) | 2010-06-29 | — | — | US | disclosed |
| US-7745642-B2 | Glycine transport inhibitors | GLAXO GROUP LIMITED (GB) | 2010-06-29 | — | — | US | disclosed |
| US-20080287547-A1 | Glycine Transport Inhibitors | GLAXO GROUP LIMITED (GB) | 2008-11-20 | — | — | US | disclosed |
| US-20080287547-A1 | Glycine Transport Inhibitors | GLAXO GROUP LIMITED (GB) | 2008-11-20 | — | — | US | disclosed |
| US-20080287547-A1 | Glycine Transport Inhibitors | GLAXO GROUP LIMITED (GB) | 2008-11-20 | — | — | US | disclosed |
| US-20070276087-A1 | MANUFACTURE OF STABLE LOW PARTICLE SIZE ORGANOPOLYSILOXANE EMUSLION | WACKER CHEMIE AG (DE) | 2007-11-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11771635-B2 | Shampoo composition | PSAP, SGMS2, ALG1 | SLC6A9 3084/4885ALDH1A1 4169/4885DRD2 1549/4885 |
| US-11679073-B2 | Hair compositions providing improved in-use wet feel | POLR1C, YWHAZ, LBR | SLC6A9 789/4885ALDH1A1 2801/4885DRD2 540/4885 |
| US-20080287547-A1 | Glycine Transport Inhibitors | SLC18A2, SLC6A5, SLC1A2 | SLC6A9 13/4885ALDH1A1 1356/4885DRD2 278/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.